Harvard Bioscience (HBIO) Shares Outstanding (2010 - 2026)

Harvard Bioscience (HBIO) has 17 years of Shares Outstanding (Entity) data on file, last reported at $4.5 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 2.01% year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 2.01% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 1.46% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $4.5 million, up from $4.5 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for HBIO reached as high as $4.5 million in Q1 2026 and fell as low as $4.1 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $4.3 million across 5 years, with a median of $4.3 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) declined 13.53% in 2022 and gained 3.12% in 2023, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $4.2 million in 2022, then rose by 3.12% to $4.3 million in 2023, then grew by 1.57% to $4.4 million in 2024, then grew by 1.46% to $4.5 million in 2025, then advanced by 0.85% to $4.5 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $4.5 million in Q1 2026, $4.5 million in Q4 2025, and $4.5 million in Q3 2025.